🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Clavulanic acid - Medicines in Ireland

25 authorised products containing Clavulanic acid, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 25 authorised medicines
MedicineActive substanceLicence holderStatus
Amoclav 250mg/125mg Film-coated Tablets
PA0711/162/002
 Amoxicillin, Clavulanic acid Rowex Limited, Not marketed
Amoclav 500mg/125mg Film-coated tablets
PA0711/162/003
 Clavulanic acid, Amoxicillin Rowex Limited, Marketed
Amoxicillin/clavulanic acid Krka 500 mg/125 mg Film-Coated Tablets
PA1347/044/001
 Amoxicillin, Clavulanic acid KRKA, d.d., Novo mesto Not marketed
Augmentin 250 mg/125 mg film-coated tablets
PA1077/093/007
 Amoxicillin, Clavulanic acid GlaxoSmithKline (Ireland) Limited Marketed
Augmentin 500 mg/125 mg film-coated tablets
PA1077/019/003
 Amoxicillin, Clavulanic acid GlaxoSmithKline (Ireland) Limited Marketed
Augmentin 875 mg/125 mg film-coated tablets
PA1077/019/005
 Amoxicillin, Clavulanic acid GlaxoSmithKline (Ireland) Limited Marketed
Augmentin 875 mg/125 mg film-coated tablets
PPA1463/242/001
 Amoxicillin, Clavulanic acid IMED Healthcare Ltd., —
Augmentin Duo Mixed Fruit 400 mg/57 mg/5 ml Powder for Oral Suspension
PA1077/019/006
 Amoxicillin, Clavulanic acid GlaxoSmithKline (Ireland) Limited Marketed
Augmentin Paediatric 125 mg/31.25 mg per 5 ml Powder for Oral Suspension
PA1077/093/004
 Amoxicillin, Clavulanic acid GlaxoSmithKline (Ireland) Limited Marketed
Clavamel Forte 500mg/125mg film-coated tablet
PA0126/243/001
 Amoxicillin, Clavulanic acid Clonmel Healthcare Ltd Marketed
Co-amoxiclav 1000 mg/200 mg powder for solution for injection/infusion
PA2220/002/002
 Amoxicillin, Clavulanic acid Instituto Biochimico Italiano G. Lorenzini S.p.A. Marketed
Co-amoxiclav 1000mg/200mg powder for solution for injection/infusion
PA2059/026/001
 Amoxicillin, Clavulanic acid Fresenius Kabi Deutschland GmbH Marketed
Co-amoxiclav 2000 mg/200 mg powder for solution for infusion
PA2220/002/003
 Amoxicillin, Clavulanic acid Instituto Biochimico Italiano G. Lorenzini S.p.A. Not marketed
Co-amoxiclav 250mg/125mg Film-coated tablets
PA23148/004/001
 Amoxicillin, Clavulanic acid Brown & Burk IR Limited Marketed
Co-amoxiclav 500 mg/100 mg powder for solution for injection/infusion
PA2220/002/001
 Amoxicillin, Clavulanic acid Instituto Biochimico Italiano G. Lorenzini S.p.A. Marketed
Co-amoxiclav 500mg/125mg Film-coated tablets
PA23148/004/002
 Amoxicillin, Clavulanic acid Brown & Burk IR Limited Marketed
Co-amoxiclav 875mg/125mg Film-coated Tablets
PA23148/004/003
 Amoxicillin, Clavulanic acid Brown & Burk IR Limited Marketed
Co-amoxiclav Bluefish 500 mg/125 mg film- coated tablets
PA1436/002/002
 Clavulanic acid, Amoxicillin trihydrate Bluefish Pharmaceuticals AB Marketed
Co-amoxiclav Bluefish 875 mg/125 mg film- coated tablets
PA1436/002/003
 Clavulanic acid, Amoxicillin trihydrate Bluefish Pharmaceuticals AB Marketed
Co-amoxiclav Sugar Free 200 mg/28.5 mg/5 ml Powder for Oral Suspension
PA23148/005/001
 Amoxicillin, Clavulanic acid Brown & Burk IR Limited Marketed
Co-Amoxiclav Sugar Free 400 mg/57 mg/5 ml Powder for Oral Suspension
PA23148/005/002
 Amoxicillin, Clavulanic acid Brown & Burk IR Limited Marketed
Co-Amoxiclav TEVA 1000 mg/200 mg Powder for Solution for Injection/Infusion
PA0749/011/002
 Amoxicillin, Clavulanic acid Teva Pharma B.V. Marketed
Co-Amoxiclav TEVA 500 mg/100 mg Powder for Solution for Injection/Infusion
PA0749/011/001
 Amoxicillin, Clavulanic acid Teva Pharma B.V. Marketed
Germentin 125 mg/31.25 mg per 5 ml Powder for Oral Suspension
PA23266/015/002
 Clavulanic acid, Amoxicillin Viatris Limited Marketed
Germentin 250 mg/125 mg Film-coated Tablets
PA23266/015/003
 Amoxicillin, Clavulanic acid Viatris Limited Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.